首页> 外文期刊>Journal of Clinical Urology >Setting up clinical research studies in the National Health Service in England
【24h】

Setting up clinical research studies in the National Health Service in England

机译:在英格兰国家卫生服务中建立临床研究研究

获取原文
获取原文并翻译 | 示例
           

摘要

Starting and conducting clinical trials in England can be a complicated and time-consuming process. Before your study can begin it is necessary to gain approval from the appropriate regulatory bodies. Prior to March 2016, studies required National Health Service (NHS) permission (also referred to as Research and Development (R&D) approval) obtained via the National Institute for Health Research (NIHR) Coordinated System for gaining NHS Permission (CSP). Since March 2016, a new streamlined system has been introduced with the aim of making it easier to gain regulatory approvals. Now studies must go through the process of Health Research Authority (HRA) approval. In this article we review the process of gaining HRA approval in England. The article is aimed at junior researchers to help them understand the application process, and to give tips on how to succeed in gaining approval.
机译:在英国的开始和进行临床试验可能是一种复杂和耗时的过程。 在您的学习开始之前,有必要从相应的监管机构获得批准。 在2016年3月之前,研究通过国家卫生研究所(NIHR)协调系统获得了国家卫生服务(NHS)许可(也称为研发(研发)批准,以获得NHS许可(CSP)。 自2016年3月以来,已经引入了一个新的简化系统,目的是更容易获得监管批准。 现在研究必须经历卫生研究局(HRA)批准的过程。 在本文中,我们审查了在英格兰获得了HRA批准的过程。 这篇文章旨在帮助他们了解申请流程的初级研究人员,并提供有关如何成功获得批准的提示。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号